Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 2
2014 4
2015 5
2016 1
2017 2
2018 1
2019 1
2020 2
2021 3
2022 3
2023 4
2024 4
2025 2
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection.
Bosch M, Kallin N, Donakonda S, Zhang JD, Wintersteller H, Hegenbarth S, Heim K, Ramirez C, Fürst A, Lattouf EI, Feuerherd M, Chattopadhyay S, Kumpesa N, Griesser V, Hoflack JC, Siebourg-Polster J, Mogler C, Swadling L, Pallett LJ, Meiser P, Manske K, de Almeida GP, Kosinska AD, Sandu I, Schneider A, Steinbacher V, Teng Y, Schnabel J, Theis F, Gehring AJ, Boonstra A, Janssen HLA, Vandenbosch M, Cuypers E, Öllinger R, Engleitner T, Rad R, Steiger K, Oxenius A, Lo WL, Klepsch V, Baier G, Holzmann B, Maini MK, Heeren R, Murray PJ, Thimme R, Herrmann C, Protzer U, Böttcher JP, Zehn D, Wohlleber D, Lauer GM, Hofmann M, Luangsay S, Knolle PA. Bosch M, et al. Among authors: kosinska ad. Nature. 2024 Jul;631(8022):867-875. doi: 10.1038/s41586-024-07630-7. Epub 2024 Jul 10. Nature. 2024. PMID: 38987588 Free PMC article.
MVA-HBVac-A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination.
Kosinska AD, Kächele M, Kerth HA, Mück-Häusl M, Ates Öz E, Gültan M, Hansen-Palmus L, Sacherl J, Ko C, Festag J, Lehmann MH, Mogler C, Steiger K, Knolle PA, Bauer T, Volz AK, Protzer U. Kosinska AD, et al. Mol Ther Nucleic Acids. 2025 Jul 23;36(3):102641. doi: 10.1016/j.omtn.2025.102641. eCollection 2025 Sep 9. Mol Ther Nucleic Acids. 2025. PMID: 40799509 Free PMC article.
HERV-K10 as a mediator of immune modulation in hepatitis infections.
Özer S, Strobelt R, Kosinska AD, Frishman G, Wettengel JM, Pleninger L, Körber N, Liang W, Ates Öz E, Zuniga M, Bauer T, Ebert G, Protzer U, Vincendeau M. Özer S, et al. Among authors: kosinska ad. Front Immunol. 2025 Sep 17;16:1624774. doi: 10.3389/fimmu.2025.1624774. eCollection 2025. Front Immunol. 2025. PMID: 41041334 Free PMC article.
Therapeutic vaccination for chronic hepatitis B.
Kosinska AD, Bauer T, Protzer U. Kosinska AD, et al. Curr Opin Virol. 2017 Apr;23:75-81. doi: 10.1016/j.coviro.2017.03.011. Epub 2017 Apr 25. Curr Opin Virol. 2017. PMID: 28453967 Review.
Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response.
Kerth HA, Kächele M, Müller N, Singh S, Tulessin M, Sacherl J, Ates Öz E, Su J, Bester R, Miko S, Steiger K, Mogler C, Busch DH, Wettengel JM, Protzer U, Kosinska AD. Kerth HA, et al. Among authors: kosinska ad. Front Immunol. 2026 Mar 12;17:1771887. doi: 10.3389/fimmu.2026.1771887. eCollection 2026. Front Immunol. 2026. PMID: 41909658 Free PMC article.
33 results